OBJECTIVE: The purpose of this study was to describe patterns of infection or colonization with antibiotic-resistant gram-negative bacilli (GNB) in hospitalized children utilizing an electronic health record. SETTING: Tertiary care facility. PARTICIPANTS: Pediatric patients 18 years of age or younger hospitalized from January 1, 2006, to December 31, 2008. METHODS: Children were identified who had (1) at least 1 positive culture for a multidrug-resistant (MDR) GNB, defined as a GNB with resistance to 3 or more antibiotic classes; or (2) additive drug resistance, defined as isolation of more than 1 GNB that collectively as a group demonstrated resistance to 3 or more antibiotic classes over the study period. Differences in clinical characteristics between the 2 groups were ascertained, including history of admissions and transfers, comorbid conditions, receipt of procedures, and antibiotic exposure. RESULTS: Of 56,235 pediatric patients, 46 children were infected or colonized with an MDR GNB, of which 16 were resistant to 3 classes and 30 were resistant to 4 classes. Another 39 patients had positive cultures for GNB that exhibited additive drug resistance. Patients with additive drug resistance were more likely than patients with MDR GNB to have had previous admissions to a long-term facility (8 vs 2; P = .04) and had more mean admissions (7 vs 3; P < .01) and more mean antibiotic-days (P < .01 to P = .02). Six patients with additive drug resistance later had a positive culture with an MDR GNB. CONCLUSIONS: An electronic health record can be used to track antibiotic class resistance in GNB isolated from hospitalized children over multiple cultures and hospitalizations.
OBJECTIVE: The purpose of this study was to describe patterns of infection or colonization with antibiotic-resistant gram-negative bacilli (GNB) in hospitalized children utilizing an electronic health record. SETTING: Tertiary care facility. PARTICIPANTS: Pediatric patients 18 years of age or younger hospitalized from January 1, 2006, to December 31, 2008. METHODS:Children were identified who had (1) at least 1 positive culture for a multidrug-resistant (MDR) GNB, defined as a GNB with resistance to 3 or more antibiotic classes; or (2) additive drug resistance, defined as isolation of more than 1 GNB that collectively as a group demonstrated resistance to 3 or more antibiotic classes over the study period. Differences in clinical characteristics between the 2 groups were ascertained, including history of admissions and transfers, comorbid conditions, receipt of procedures, and antibiotic exposure. RESULTS: Of 56,235 pediatric patients, 46 children were infected or colonized with an MDR GNB, of which 16 were resistant to 3 classes and 30 were resistant to 4 classes. Another 39 patients had positive cultures for GNB that exhibited additive drug resistance. Patients with additive drug resistance were more likely than patients with MDR GNB to have had previous admissions to a long-term facility (8 vs 2; P = .04) and had more mean admissions (7 vs 3; P < .01) and more mean antibiotic-days (P < .01 to P = .02). Six patients with additive drug resistance later had a positive culture with an MDR GNB. CONCLUSIONS: An electronic health record can be used to track antibiotic class resistance in GNB isolated from hospitalized children over multiple cultures and hospitalizations.
Authors: Theoklis E Zaoutis; Monika Goyal; Jaclyn H Chu; Susan E Coffin; Louis M Bell; Irving Nachamkin; Karin L McGowan; Warren B Bilker; Ebbing Lautenbach Journal: Pediatrics Date: 2005-04 Impact factor: 7.124
Authors: Anthony D Harris; Mamuka Kotetishvili; Simone Shurland; Judy A Johnson; J Glenn Morris; Lucia L Nemoy; J Kristie Johnson Journal: Am J Infect Control Date: 2007-03 Impact factor: 2.918
Authors: A D Harris; E N Perencevich; J K Johnson; D L Paterson; J G Morris; S M Strauss; J A Johnson Journal: Clin Infect Dis Date: 2007-10-16 Impact factor: 9.079
Authors: Bevin Cohen; David K Vawdrey; Jianfang Liu; David Caplan; E Yoko Furuya; Frederick W Mis; Elaine Larson Journal: Policy Polit Nurs Pract Date: 2015-09-08
Authors: Meghan T Murray; Marianne Pavia; Olivia Jackson; Mary Keenan; Natalie M Neu; B Cohen; Lisa Saiman; Elaine L Larson Journal: Am J Infect Control Date: 2015-04-29 Impact factor: 2.918